Astellas Pharma | 4503 - Gross Profit On Sales


Astellas Pharma reported JPY482.54B in Gross Profit on Sales for its fiscal quarter ending in June of 2026.





Gross Profit On Sales Change Date
Astellas Pharma JPY 482.54B 38.28B Jun/2026
Chugai Pharma JPY 237.37B 21.38B Jun/2026
Daiichi Sankyo JPY 287.15B 152.68B Mar/2026
Eisai JPY 183.24B 29.83B Jun/2026
Kyowa Hakko Kirin JPY 109.03B 20.79B Jun/2026
M3 JPY 44.46B 2.58B Jun/2026
Otsuka Holdings JPY 456.25B 1.16B Mar/2026
Shionogi JPY 132.52B 21.62B Jun/2026
Sumitomo Dainippon JPY 54.28B 19.25B Mar/2026
Takeda JPY 813.22B 124.39B Jun/2026
Terumo JPY 178.54B 29.52B Jun/2026